STOCK RESEARCH AI Institutional Equity Engine
Equities & Institutional Dossiers • 7-Pillar Forensic Engine

Institutional Equities Directory

Exhaustive institutional equity research repository covering all 145 verified Indian equities. Every dossier is grounded in primary exchange filings (BSE/NSE), featuring 7-Pillar health scorecards, reverse DCF implied growth rates, DuPont ROE decompositions, and promoter pledging surveillance.

Monitored Equities
145 Companies
Combined Market Cap
₹190 Lakh Cr
Median Capital Return (ROCE)
20.4%
Median Trailing Valuation
33.7x P/E
Featured Institutional Equity Spotlight • 7-Pillar Dossier

INFY

₹1,024.05 Mega-Cap
Infosys Ltd • IT & Technology • Market Cap: ₹415,588 Cr • 9 Institutional Revisions
ROCE (Capital Return)
42.8%
Debt-to-Equity
9.54x
Trailing P/E
13.9x
Operating Margin
21.2%
Market Cap
₹415,588 Cr
Inspect Full Institutional Dossier → Last Evaluated: 10-10-2026 00:44 IST
All Equities (145) 💻 IT & Technology (30) 🏛️ BFSI & Financials (11) 🔬 Healthcare & Pharma (6) ⚙️ Capital Goods & Infra (11) 🚗 Automotive & Mobility (12) 🛍️ Consumer & Retail (7) 🧪 Chemicals & Materials (5) ⚡ Energy & Commodities (15) 🛡️ EMS & Defence (3) 🏭 Diversified Industrials (45)
Cap Size: All Mega-Cap (>₹1L Cr) Large-Cap (₹25k–1L Cr) Mid-Cap (₹5k–25k Cr) Small-Cap (<₹5k Cr)
Showing 1 of 145 Institutional Equities in Healthcare & Pharma
🎯 Opportunity Terminal 💼 Mutual Funds Look-Through
🔬 Healthcare & Pharma
Mid-Cap 1 revs

COHANCE

₹440.60
Cohance Lifesciences Ltd
ROCE
24.1%
D/E
0.03x
P/E
160.8x
Market Cap: ₹16,857 Cr OPM: 25.0%
Inspect Full Dossier →

Statutory Regulatory Disclosure: Stock Research AI is an independent software tool and research analytical engine. We are not registered as a SEBI Research Analyst (RA) or Investment Adviser (IA). All quantitative metrics, DuPont ROE decompositions, and reverse DCF valuations are deterministic computational representations grounded in verified historical corporate disclosures published by the BSE and NSE.

Nothing on this page constitutes an offer, solicitation, or recommendation to buy, hold, or liquidate any security. Historical performance does not guarantee future market outcomes. Consult a SEBI-registered professional before making investment decisions.